Heather Koshinsky, PhD, serves as chair of the Bio+Health Track at Berkeley SkyDeck, UC Berkeley’s premier startup accelerator supporting the intersection of biology, healthcare, and technology. She is also the vice president of innovation and brand integrity at LevGo, which develops and manufactures laboratory consumables in China, the European Union, and the United States, with global distribution. As a serial entrepreneur, she has previously co-founded four successful startups. Notably, she was the co-founder and CEO at Investigen, which receives royalty revenue for its IP, and co-founder and CSO at Eureka Genomics, which developed Eureka Genotyping that Thermo Fisher Scientific now sells internationally.

Dr. Koshinsky is a member of several incubators and accelerators located in the United States and Canada, and is/has been an advisor and/or board member to startups located in Poland, China, Taiwan, Philippines, India, the United Kingdom, Australia, the United States, and Canada, covering fields including novel and repurposed drugs, medical devices and diagnostics, vaccines, bioreactors, remote sensing in agriculture, low-light imaging chips, and big data analysis software for single-cell immunogenetics. A grant reviewer for over 20 years, an inventor on multiple patent families, and author of numerous papers, Dr. Koshinsky earned her PhD in microbiology from the University of Saskatchewan and certificates in business administration and marketing from UC Berkeley Extension.